Source: Translational Cancer Research. Unidades: ICB, FM
Subjects: FARMACOLOGIA, LEUCEMIA MIELOIDE AGUDA, CITOESQUELETO, HEMATOPOESE, EXPRESSÃO GÊNICA, MONÓCITOS, MUTAÇÃO, MICRORNAS, GRANULÓCITOS, BIOINFORMÁTICA
ABNT
VICARI, Hugo Passos et al. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, v. 13, n. 11, p. 6105-6116, 2024Tradução . . Disponível em: https://dx.doi.org/10.21037/tcr-24-1091. Acesso em: 08 out. 2025.APA
Vicari, H. P., Silva, J. C. L. da, Carvalho, M. F. L., Lima, K., & Machado Neto, J. A. (2024). Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes. Translational Cancer Research, 13( 11), 6105-6116. doi:10.21037/tcr-24-1091NLM
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091Vancouver
Vicari HP, Silva JCL da, Carvalho MFL, Lima K, Machado Neto JA. Emerging functions of FMNL1 in myeloid neoplasms: insights from bioinformatics to biological and pharmacological landscapes [Internet]. Translational Cancer Research. 2024 ; 13( 11): 6105-6116.[citado 2025 out. 08 ] Available from: https://dx.doi.org/10.21037/tcr-24-1091